Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (6)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Crespi, M.
Right arrow Articles by Lisi, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crespi, M.
Right arrow Articles by Lisi, D.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Annals of Oncology 13:47-50, 2002
© 2002 European Society for Medical Oncology

Debate

Is colorectal cancer screening by fecal occult blood feasible?

M. Crespi1,+ and D. Lisi2

1National Cancer Institute ‘Regina Elena’, Rome; 2Superior Institute of Health, Rome, Italy

Received 9 August 2001; accepted 10 October 2001.

cancer screening, colorectal cancer, occult blood

Introduction

Colorectal cancer represents the second most frequent neoplasia in mortality statistics of western countries.

In Europe in 1996, there were 213 111 cases and 110 669 deaths from colorectal cancer (Table 1) [1]. The trend in incidence from 1970 projected to 2006 (R. Capocaccia and A. Verdecchia, personal communication) shows a steady increase in all European countries, whereas in the USA there has been a downward trend since 1985 [2]. These differences may be partially explained by the diffusion of endoscopic procedures (colonoscopy) with the related removal of precursor lesions, namely adenomatous polyps. In fact, in a recent report by Lieberman et al. [3], 36.6% of 17 732 average risk subjects invited for a screening colonoscopy had already had a colonic examination performed in the previous 10 years. In addition, a downward trend in colorectal cancer mortality was observed in the USA from . . . [Full Text of this Article]

Fecal occult blood testing

Discussion

Footnotes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Ann OncolHome page
P. Boyle, H. Vainio, R. Smith, R. Benamouzig, W. C. Lee, N. Segnan, K. Takima, and Y. Tsubono
Workgroup I: criteria for screening. UICC International Workshop on Facilitating Screening for Colorectal Cancer, Oslo, Norway (29 and 30 June 2002)
Ann. Onc., January 1, 2005; 16(1): 25 - 30.
[Full Text] [PDF]

Home page
 The OncologistHome page
J. Crown, M. O'Leary, and W.-S. Ooi
Docetaxel and Paclitaxel in the Treatment of Breast Cancer: A Review of Clinical Experience
Oncologist, June 2, 2004; 9(suppl_2): 24 - 32.
[Abstract] [Full Text] [PDF]

Home page
 Eur Respir JHome page
P. Boyle
Screening
Eur. Respir. J., January 1, 2003; 21(39_suppl): 3S - 15s.
[Abstract] [Full Text] [PDF]

Home page
 Ann OncolHome page
P. Boyle
Faecal occult blood testing (FOBT) as screening for colorectal cancer: the current controversy
Ann. Onc., January 19, 2002; 13(1): 16 - 18.
[Full Text] [PDF]